Ligand Pharmaceuticals | Des Atouts

Prix De L'Action
205.32
Variation Quotidienne
2.77 1.37%
Mensuellement
3.52%
Annuel
78.14%
Q1 Prévisions
192.24




Des Atouts Changement Date
Agenus USD 233.89M 48.67M 2025-09
Amgen USD 90.59B 445M 2025-12
Anika Therapeutics USD 189.44M 1.76M 2025-09
Arrowhead Research USD 1.6B 218.89M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Eli Lilly USD 112.48B 2.46B 2025-12
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Enviri Corporation USD 2.79B 23.29M 2025-09
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Heron Therapeutics USD 248.95M 16.86M 2025-09
Insmed USD 2.26B 96.18M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
MacroGenics USD 270.76M 25.34M 2025-09
Merck USD 129.55B 12.02B 2025-09
Pacira USD 1.26B 32.66M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Veracyte USD 1.41B 38.23M 2025-12


Ligand Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.